1. Home
  2. Search Clinical Trials
Search
Filters
Clear All
  • 18
  • 28
  • 2
  • 171

Phase

  • 5
  • 3
  • 2
  • 6
  • 4
  • 3
  • 157
  • 207
  • 67
  • 217
  • 2
  • 15
  • 4
  • 1
  • 218

Found 219 cancer trials

A listing of cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:

An Open-label Multicenter Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects >=1 and =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

1 years - 30 years
All genders
The purpose of this study is to see if Daratumumab is useful for treating pediatric (subjects aged >=1 to 18 years) and young adult patients (aged 18 to 30 years) with acute lymphoblastic leukemia or lymphoblastic lymphoma.
Learn More

Breast Cancer Survivors and Their Partners Needed for Research Study!

100 years or below
All genders
ARE YOU OR SOMEONE YOU KNOW A BREAST CANCER SURVIVOR?  We need your help! Researchers at Purdue University are looking for breast cancer survivors and their romantic partners to take part in a study exploring how relationships and stress affect couples' immune and cardiovascular systems during survivorship.Couples in survivorship who are living and …
Check Eligibility

Study of Testing in People Interested in Research Participation

Male
The purpose of this research study is to learn about testing in people who are interested in participating.Participants will take part in testing as part of the study.
Check Eligibility

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

18 years or above
Female
Phase 3
This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive …
Learn More

Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release

100 years or below
All genders
The purpose of this Managed Access Program (MAP) Treatment Plan is to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release where no overwhelming safety concerns has been …
Learn More

Phase I trial of azacitidine plus nivolumab following reduced-intensity allogeneic PBSC transplantation for patients with AML and high-risk myelodysplasia

18 years - 100 years
All genders
The purpose of this study is to find the maximum safe dose of nivolumab alone, and of nivolumab combined with azacitidine after reduced-intensity allogeneic peripheral blood stem cell (PBSC) transplantation. Another purpose is to see how the study drugs affect different aspects of transplant such as infection and disease response.
Learn More

Api post curl command

21 years - 100 years
Male
Observational
Sample.
Check Eligibility

abc test

100 years or below
Male
Phase 1
ne wtest
Check Eligibility

Host Genome Methylation: a Screening Tool in Anal Cancer Detection (AMethysT)

18 years or above
All genders
Interventional
In January 2023, the first recommendations for anal cancer screening were issued by the French National Society of Coloproctology (SNFCP). These were the world's first national recommendations for anal cancer screening for at-risk patients, not limited to people living with HIV. They are based on screening for papillomavirus type 16 …
Learn More

A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

18 years - 100 years
All genders
Phase 2/3
Interventional
This study will compare the effects, good and/or bad, of radiation and chemotherapy to radiation alone in salivary gland cancer to find out which is better at reducing the chance that the cancer will come back.
Learn More
181 - 190 of 219